The weekly litigation news digest is live. Subscribe now

IP Verse

Aqueous Pharmaceutical Formulation Of Tapentadol For Oral Administration - EP3287123

The patent EP3287123 was granted to Grnenthal on Apr 22, 2020. The application was filed on Mar 2, 2012 under application number EP17189271A. The patent is currently recorded with a legal status of "Revoked".

EP3287123

GRNENTHAL
Application Number
EP17189271A
Filing Date
Mar 2, 2012
Status
Revoked
Jul 21, 2023
Publication Date
Apr 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LABOMED PHARMACEUTICAL COMPAMYJan 22, 2021ROUKOUNASADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007128412
DESCRIPTIONWO02067651
DESCRIPTIONWO03035053
DESCRIPTIONWO2006002886
DESCRIPTIONWO2007128412
DESCRIPTIONWO2007128413
DESCRIPTIONWO2008110323
DESCRIPTIONWO2009067703
DESCRIPTIONWO2009092601
OPPOSITIONWO02067651
OPPOSITIONWO2008110323
OPPOSITIONWO2008128740
OTHERWO02067651
OTHERWO2008110323
SEARCHUS2010272815
SEARCHWO02067651
SEARCHWO2007128412
SEARCHWO2008110323

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents